If you are considering selling medical devices in Southeast Asia, Malaysia is almost unavoidable as the first stop. The country has one of the most complete medical device regulatory systems in Southeast Asia, a mature market and clear policies, and regulatory cooperation between China and Malaysia has continued to deepen in recent years.
This article takes you through it from the start: how big is Malaysia’s medical device market? How do you register? How long does it take?
01 How Big Is the Market? Some Numbers First
In 2023, Malaysia’s medical device market exceeded RM 7 billion (about USD 1.5 billion), and the hospital market reached RM 10.6 billion. Between 2025 and 2030 the overall market is expected to grow at a CAGR of 8%–10%, potentially exceeding USD 16 billion by 2030.
This growth is driven by three engines working together:
-
Higher healthcare spending driven by rising incomes
-
Equipment demand from a rapidly ageing population
-
The government’s commitment to raise healthcare spending by about 4% a year
China–Malaysia regulatory reliance pilot: a policy development worth watching for IVD companies
In November 2023, China’s NMPA (National Medical Products Administration) and Malaysia’s MDA signed a Memorandum of Understanding (MoU) on medical device cooperation, and on 30 July 2025 formally launched Pilot Phase I, with an application window from 30 July to 30 September 2025.
A few points should be stated accurately:
-
The scope is limited to IVD (in vitro diagnostic) products; general medical devices are not yet covered;
-
Pilot Phase I closed on 30 September 2025; whether a second phase follows depends on official MDA announcements;
-
If later phases are formally implemented, NMPA-certified IVD products may use the Verification Pathway, with approval potentially cut to 30 working days.
02 Regulatory Framework: Who Decides?
Medical device regulation in Malaysia is based on the Medical Device Act 2012 (Act 737), administered by the MDA (Medical Device Authority) under the Ministry of Health, in force since 1 July 2013.
Any medical device intended to be imported, exported or sold in Malaysia must first be registered with the MDA before it can be lawfully placed on the market – no exceptions!
03 Which Class Is Your Product?
Malaysia classifies medical devices into four classes by risk, which directly determines your registration route and review time:
Class A products do not require CAB conformity assessment and have the simplest registration process – a good way to enter the Malaysian market early.
04 Six Steps to Registration
The registration process can be broken down into six key steps; once you understand each, the process is far less daunting:
-
Appoint a local Authorized Representative (AR) – overseas manufacturers must designate an AR in Malaysia who bears all registration obligations
-
Confirm the device class – determine the applicable class based on intended use and risk
-
Conformity assessment (CAB assessment) – Class B/C/D must be audited by a recognized body; Class A is exempt
-
Prepare the dossier and submit it via MeDC@St – the complete technical file is submitted online through the MDA’s official platform
-
MDA review and evaluation – the official review period begins
-
Approval and certificate – the registration certificate is issued and the product can lawfully enter the Malaysian market
05 Review Times and Fees
Time and money are what every company cares about; here is a summary:
All fees are in Malaysian ringgit (RM), source: Fifth Schedule of the MDA’s Medical Device Regulations 2012. Class A fees are the new rates adjusted from 1 January 2026; Class B/C/D fees remain unchanged. Note: these are official registration fees and exclude CAB (conformity assessment body) assessment fees and agent service fees.
06 Already Have Overseas Approval? Use the Simplified Route
If your product has been approved by any of the following, you can use a simplified review route in Malaysia, saving considerable time:
-
US FDA (Food and Drug Administration)
-
EU CE certification
-
Australia TGA (Therapeutic Goods Administration)
-
UK MHRA (Medicines and Healthcare products Regulatory Agency)
-
Japan PMDA (Pharmaceuticals and Medical Devices Agency)
-
China NMPA (National Medical Products Administration)
China NMPA approval is also on the list recognized for Malaysia’s simplified route. Combined with the China–Malaysia reliance pilot (IVD products only), this may further shorten approval times – subject to the latest MDA announcements.
07 Getting the Certificate Is Not the End: What You Need to Do After Launch
Certification is only the starting point; ongoing compliance is the baseline for operations. The main post-market requirements are:
▶ Registration valid for 5 years: renewal must be applied for via MeDC@St 1 year before expiry – don’t leave it to the last minute.
▶ Post-Market Surveillance (PMS): manufacturers must maintain complete distribution records, complaint handling procedures and adverse event reporting mechanisms.
▶ Mandatory adverse event reporting: reporting deadlines depend on severity and must be met as required.
▶ Labeling compliance: labels must show the MDA registration number and local AR contact details; IFUs for home-use devices must be provided in Malay (Bahasa Malaysia).
▶ Import permits: from 2 January 2026, each import shipment requires a permit via the ePermit/DagangNet system – prepare your system connection in advance.